Jyong Biotech (MENS) Income Statement (2023 - 2025)
Annual Income Statement report data from Dec 31, 2023 to Dec 31, 2025 for Jyong Biotech (MENS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| 2025 | 2024 | 2023 | |
|---|---|---|---|
Operating Expenses | |||
Research And Development | 810K (-12.90%) | 930K (-13.08%) | 1.07M |
Selling General And Administrative | 1.75M (+60.55%) | 1.09M (-35.12%) | 1.68M |
Operating Expenses | 2.61M (+26.70%) | 2.06M (-26.43%) | 2.80M |
Depreciation And Amortization | 100K (-16.67%) | 120K (-7.69%) | 130K |
Operating Income | |||
Operating Income | -2.61M (+26.70%) | -2.06M (-26.43%) | -2.80M |
Ebit | -2.61M (+26.70%) | -2.06M (-26.43%) | -2.80M |
EBITDA | -2.51M (+29.38%) | -1.94M (-27.34%) | -2.67M |
Other Income / Expenses | |||
Interest Income | 610K (+6000.00%) | 10K (-83.33%) | 60K |
Interest Expense | 2.54M (+146.60%) | 1.03M (+35.53%) | 760K |
Net Interest Income | 610K (+6000.00%) | 10K (-83.33%) | 60K |
Other Non Operating Income | -2.06M (+114.58%) | -960.00K (-40.00%) | -1.60M |
Net Income | |||
Income Before Tax | -4.67M (+54.64%) | -3.02M (-31.36%) | -4.40M |
Net Income From Continuing Operations | -4.67M (+54.64%) | -3.02M (-31.36%) | -4.40M |
Net Income | -4.67M (+54.64%) | -3.02M (-31.36%) | -4.40M |
Comprehensive Income Net Of Tax | -5.11M (+108.57%) | -2.45M (-44.82%) | -4.44M |